Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study.

Autor: Oreja-Guevara C; Department of Neurology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain; Department of Medicine, Medicine University, Complutense University of Madrid (UCM), Madrid, Spain. Electronic address: coreja@ucm.es., Meca-Lallana JE; CSUR Multiple Sclerosis and Clinical Neuroimmunology Unit, Neurology Department, Virgen de la Arrixaca Clinical University Hospital, IMIB-Arrixaca, Murcia, Spain., Díaz-Díaz J; Department of Neurology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain., Ara JR; Neurology Department, Miguel Servet University Hospital, Zaragoza, Spain., Hernández Pérez MÁ; Neurology Department, Nuestra Señora de la Candelaria University Hospital, Santa Cruz de Tenerife, Spain., Gracia Gil J; Neurology Department, Albacete University Hospital Complex, Albacete, Spain., Alonso Torres AM; CSUR Multiple Sclerosis, Neurology Department, Málaga Regional University Hospital, Málaga, Spain., Pilo de la Fuente B; Neurology Department, Getafe University Hospital, Madrid, Spain., Ramió-Torrentà L; Neuroimmunology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital, IDIBGI, Girona, Spain., Eichau Madueño S; Neurology Department, Virgen Macarena University Hospital, Sevilla, Spain., Gascón-Giménez F; Neurology Department, Hospital Clínico de Valencia, Valencia, Spain., Casanova B; Neuroinmunology Unit, University and Polytechnic La Fe Hospital, València, Spain., Martínez-Yélamos S; Neurology Department, Bellvitge-IDIBELL University Hospital, L'Hospitalet De Llobregat, Barcelona, Spain., Aguado Valcárcel M; Neurology Department, Hospital Álvaro Cunqueiro, Vigo, Spain., Martínez Ginés ML; Neurology Department, Hospital Gregorio Marañón, Madrid, Spain., El Berdei Montero Y; Neurology Department, Salamanca University Hospital, Salamanca, Spain., López Real AM; Neurology Department, A Coruña University Hospital Complex, A Coruña, Spain., González-Quintanilla V; Neurology Department, Marqués de Valdecilla University Hospital, Cantabria, Spain., De Torres L; Neurology Department, Torrejón University Hospital, Madrid, Spain., Martínez-Rodríguez JE; Neurology Department, Hospital del Mar, Barcelona, Spain., Costa-Frossard L; Neurology Department, Ramón y Cajal University Hospital, Madrid, Spain., Garcés Redondo M; Neurology Department, Lozano Blesa Clinical University Hospital, Zaragoza, Spain., Labiano Fontcuberta A; Neurology Department, 12 de Octubre University Hospital, Madrid, Spain., Castellanos-Pinedo F; Neurology Department, Hospital Virgen del Puerto Plasencia, Cáceres, Spain., García Merino JA; Neurology Department, Puerta de Hierro University Hospital, Madrid, Spain., Muñoz Fernández C; Neurology Department, Torrecárdenas University Hospital, Almería, Spain., Castillo-Triviño T; Neurology Department, Donostia University Hospital, San Sebastián, Spain., Meca-Lallana V; Neurology Department, La Princesa University Hospital, Madrid, Spain., Peña Martínez J; Neurology Department, San Agustín University Hospital, Avilés, Asturias, Spain., Rodríguez-Antigüedad A; Neurology Department, Cruces-BioCruces Bizkaia University Hospital, Barakaldo-Bizkaia, Spain., Prieto González JM; Neurology Department, Santiago Clinical University Hospital, Instituto de Investigaciones Sanitarias de Santiago, Santiago de Compostela, Spain., Agüera Morales E; Neurology Department, Reina Sofia University Hospital, Córdoba, Spain., Pérez Molina I; Neurology Department, Hospital Virgen de la Salud, Toledo, Spain., Solar Sánchez DM; Neurology Department, Cabueñes University Hospital, Gijón, Spain., Herrera Varo N; Neurology Department, Burgos University Hospital, Burgos, Spain., Romero Sevilla R; Novartis Farmacéutica, S.A., Barcelona, Spain., Gómez Vicente L; Novartis Farmacéutica, S.A., Barcelona, Spain., Río J; Neurology Department, CEMCAT, Vall d'Hebrón University Hospital, Barcelona, Spain.

Publikováno v: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Oct; Vol. 90, pp. 105787. Date of Electronic Publication: 2024 Aug 02.

Influenza Vaccination Coverage among Multiple Sclerosis Patients: Evolution over Time and Associated Factors

Autor: Hernández-García, I., Garcés Redondo, M., Rodríguez-Montolio, J., Bengoa-Urrengoechea, I., Espinosa-Rueda, J., Aibar Remón, C., Vaccine Working Group

Publikováno v: Vaccines; Volume 10; Issue 7; Pages: 1154
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname

Our objective was to determine the influenza vaccination rate in a Spanish cohort of multiple sclerosis (MS) patients. A retrospective cohort study was carried out. Patients who attended the MS unit of the Lozano Blesa Hospital of Zaragoza between Ja

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7aea45bb81be227e9c99adb9e85dbc0

Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach.

Autor: Sainz de la Maza S; Department of Neurology, Hospital Universitario Ramón y Cajal, IRyCIS, Universidad de Alcalá, Madrid, Spain., Gómez-Ballesteros R; Medical Department, Roche Farma, Madrid, Spain., Borges M; Department of Neurology, Hospital Universitario Virgen Macarena, Sevilla, Spain., Martín-Martínez J; Department of Neurology, Hospital Universitario Miguel Servet, Zaragoza, Spain., Sotoca J; Department of Neurology, Hospital Universitari Mútua Terrassa, Terrassa, Spain., Alonso A; Department of Neurology, Hospital Regional Universitario de Málaga, Málaga, Spain., Caminero AB; Department of Neurology, Complejo Asistencial de Ávila, Ávila, Spain., Borrega L; Department of Neurology, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain., Sánchez-Menoyo JL; Department of Neurology, Hospital de Galdakao-Usansolo, Galdakao, Spain., Barrero-Hernández FJ; Department of Neurology, Hospital Universitario Clínico San Cecilio, Granada, Spain., Calles C; Department of Neurology, Hospital Universitari Son Espases, Palma de Mallorca, Spain., Brieva L; Department of Neurology, Hospital Universitari Arnau de Vilanova, Lleida, Spain., Blasco-Quílez MR; Department of Neurology, Hospital Universitario Puerta de Hierro, Madrid, Spain., Dotor García-Soto J; Department of Neurology, Hospital Universitario Virgen Macarena, Sevilla, Spain., Del Campo-Amigo M; Department of Neurology, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain., Navarro-Cantó L; Department of Neurology, Hospital General Universitario de Elche, Elche, Spain., Agüera E; Department of Neurology, Hospital Universitario Reina Sofía, Córdoba, Spain., Garcés-Redondo M; Department of Neurology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain., Carmona O; Department of Neurology, Fundació Salut Empordà, Figueres, Spain., Gabaldón-Torres L; Department of Neurology, Hospital Francesc de Borja, Gandía, Spain., Forero L; Department of Neurology, Hospital Universitario Puerta del Mar, Cádiz, Spain., Hervàs M; Department of Neurology, Consorci Corporació Sanitària Parc Taulí, Sabadell, Spain., Medrano N; Medical Department, Roche Farma, Madrid, Spain., Maurino J; Medical Department, Roche Farma, Madrid, Spain., Castillo-Triviño T; Department of Neurology, Hospital Universitario Donostia, San Sebastián, Spain.

Publikováno v: Multiple sclerosis journal - experimental, translational and clinical [Mult Scler J Exp Transl Clin] 2023 May 10; Vol. 9 (2), pp. 20552173231169475. Date of Electronic Publication: 2023 May 10 (Print Publication: 2023).

Influenza Vaccination among Multiple Sclerosis Patients during the COVID-19 Pandemic.

Autor: Hernández-García I; Department of Preventive Medicine and Public Health, Lozano Blesa University Clinical Hospital of Zaragoza, Calle San Juan Bosco 15, 50009 Zaragoza, Spain.; Health Services Research Group of Aragon (GRISSA), Aragon Institute for Health Research (IISA), Calle San Juan Bosco 15, 50009 Zaragoza, Spain., Garcés-Redondo M; Department of Neurology, Lozano Blesa University Clinical Hospital of Zaragoza, Calle San Juan Bosco 15, 50009 Zaragoza, Spain., Espinosa-Rueda J; Department of Neurology, Lozano Blesa University Clinical Hospital of Zaragoza, Calle San Juan Bosco 15, 50009 Zaragoza, Spain., Rodríguez-Montolio J; Department of Neurology, Lozano Blesa University Clinical Hospital of Zaragoza, Calle San Juan Bosco 15, 50009 Zaragoza, Spain., Bengoa-Urrengoechea I; Department of Preventive Medicine and Public Health, Lozano Blesa University Clinical Hospital of Zaragoza, Calle San Juan Bosco 15, 50009 Zaragoza, Spain.; Health Services Research Group of Aragon (GRISSA), Aragon Institute for Health Research (IISA), Calle San Juan Bosco 15, 50009 Zaragoza, Spain., Aibar-Remón C; Department of Preventive Medicine and Public Health, Lozano Blesa University Clinical Hospital of Zaragoza, Calle San Juan Bosco 15, 50009 Zaragoza, Spain.; Health Services Research Group of Aragon (GRISSA), Aragon Institute for Health Research (IISA), Calle San Juan Bosco 15, 50009 Zaragoza, Spain.; Department of Preventive Medicine and Public Health, University of Zaragoza, Calle de Pedro Cerbuna 12, 50009 Zaragoza, Spain.

Publikováno v: Vaccines [Vaccines (Basel)] 2022 Oct 21; Vol. 10 (10). Date of Electronic Publication: 2022 Oct 21.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.